Bixiye
QP73-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective November 1, 2022
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 14, 2022
Natiijooyinka Raadinta
Soo bandhiga 1671 - 1680 ee natiijooyinka 3688
Bixiye
P52-22 Enhanced Asthma Benefits for Minnesota Health Care Programs (MHCP) Members
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2022
Bixiye
P53-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates Effective October 31, 2022
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2022
Bixiye
QP77-22 Reminder: Submit Finger and Toe Anatomical Modifiers
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 28, 2022
Bixiye
QP78-22 Laboratory Reimbursement Policy Change will not be Implemented
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 28, 2022
Bixiye
QP72-22 Executive Physical information added to Provider Policy and Procedure Manual
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 14, 2022
Bixiye
QP75-22 MHCP Pharmacy Benefit Exclusion for Alymsys® Byooviz™ and Igalmi™
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 14, 2022
Bixiye
P55-22 eviCore Healthcare Specialty Utilization Management (UM) Program: Radiation Oncology Clinical Guideline Updates
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2022
Bixiye
P56-22 eviCore Healthcare Specialty Utilization Management (UM) Program: Sleep Management Clinical Guideline Updates
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2022
Bixiye
2022 September Bulletins
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2022